In its February 2024 meeting, the European Medicines Agency's Committee for Medicinal Products for Human Use has granted marketing authorizations for Pyzchiva , which was authorized in the EU in 2009. The EMA added that data showed that Pyzchiva has comparable quality, safety, and efficacy to Stelera.
For the treatment of plaque psoriasis and psoriatic arthritis, the drug is usually injected subcutaneously every 4 weeks for the first two doses and then every 12 weeks for as long as treatment continues.
Active psoriatic arthritis — alone or in combination with methotrexate — in adult patients when the response to previous non-biological disease-modifying anti- rheumatic drug therapy has been inadequate. Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies.Apremilast Accord is a phosphodiesterase 4 inhibitor for the treatment of psoriatic arthritis, psoriasis, and Behçet disease.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Allure_magazine - 🏆 473. / 51 Read more »
Source: SELFmagazine - 🏆 478. / 51 Read more »
Source: SELFmagazine - 🏆 478. / 51 Read more »
Source: MsMagazine - 🏆 378. / 59 Read more »
Source: TeenVogue - 🏆 481. / 51 Read more »
Source: LAist - 🏆 606. / 51 Read more »